Questions? Call 888-624-8373

HARDBACK + PDF
your price: $53.00
add to cart

HARDBACK
list:$45.00
Web:$40.50
add to cart

PDF BOOK
your price: $34.50
add to cart

PDF CHAPTERS
your price: $3.60
select

Rights & Permissions

topleft topright

The Resistance Phenomenon in Microbes and Infectious Disease Vectors: Implications for Human Health and Strategies for Containment -- Workshop Summary (2003)
Board on Global Health (BGH)
Institute of Medicine (IOM)

Page
255
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Medina-Cuevas F, Navarrete-Navarro S, Avila-Figueroa C, Santos-Preciado JI. 2000. FARMAC: a program designed for monitoring the prescription of antimicrobials in hospitals (abstract only). Gaceta médica de México136(2):107–111.


OIE (Office International des Epizooties). The Use of Antibiotics in Animals—Ensuring the Protection of Public Health. March 24–26, 1999. Summary and Recommendations from the European Scientific Conference. Available at: http://www.antibiotics-conference.net/site/conclusn/summary.htm.


Schentag JJ, Gilliland KK, Paladino JA. 2001. What have we learned from pharmacokinetic and pharmacodynamic theories?Clinical Infectious Diseases32 Suppl 1:S39–S46. Available at: http://www.journals.uchicago.edu/CID/journal/issues/v32nS1/000683/000683.html.

Schrag SJ, Beall B, Dowell SF. 2000. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.Clinical Microbiology Reviews13(4):588–601. Available at: http://cmr.asm.org/cgi/content/full/13/4/588?view=full&pmid=11023959.

Shlaes DM, Gerding DN, John JF Jr, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE Jr, Paul SM, Ruskin J, Tenover FC, Watanakunakorn C. 1997. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the Prevention of Antimicrobial Resistance in Hospitals. Infection Control and Hospital Epidemiology18(4):275–291.


World Health Organization. 2001. WHO Global Strategy for Containment of Antimicrobial Resistance. Available at: http://www.who.int/emc/amrpdfs/WHO_Global_Strategy_English.pdf.

Insecticide Resistance/Vector Control

Insecticide Resistance Management: A Driving Force for New Insecticide Development. 2001. Down to Earth56(1): 8–9. Available at: http://www.dowagro.com/webapps/lit/litorder.asp?objid=09002f138016e140&filepath=/noreg.


McGaughey WH, Gould F, Gelernter W. 1998. Bt resistance management. Nature Biotech nology16(2):144–146.


Rose RI. 2001. Pesticides and public health: integrated methods of mosquito management. Emerging Infectious Diseases7(1):17–23. Available at: http://www.cdc.gov/ncidod/eid/vol7no1/rose.htm.


Sina BJ, Aultman K. 2001. Resisting resistance. Trends in Parasitology17(7):305–306.


World Health Organization Communicable Disease Control, Prevention and Eradication, WHO Pesticide Evaluation Scheme (WHOPES). 2000. Report of the Second Meeting of the Global Collaboration for Development of Pesticides for Public Health (GCDPP). April 6–7, 2000. Available at: http://www.who.int/ctd/whopes/gcdpp2.pdf.

Page
255